Montalcini Global Biotech Tour
Join an exclusive evening connecting Italy's world-class biotech ecosystem with Boston's innovation leaders.
The Montalcini Global Biotech Tour - which launched this year in San Francisco during the JP Morgan Conference and continued in Doha - now arrives in Boston to consolidate Italy's presence in key international life sciences hubs.
Named after Nobel Prize winner Rita Levi-Montalcini, who pioneered her groundbreaking research between Italy and the US, this prestigious gathering features senior executives from Takeda, Novo Nordisk, Portal Bio, and Italy's leading biotech organizations.
📋Featured Speaker Program:
6:00 PM - Guests Registration
6:30 PM - Opening Remarks
Arnaldo Minuti - Consul General of Italy in Boston
Erica Di Giovancarlo - Trade Commissioner Italian Trade Agency New York Office and Executive Director of ITA US Network
6:40 PM - The Italian Biotech Ecosystem
Massimo Carnelos - Head of Technological Innovation, Italian Ministry of Foreign Affairs and International Cooperation
Mario Scuderi - Senior Partner & Head of Evolution Fund, CDP Venture Capital
7:00 PM - Fireside Chat: Unlocking Opportunities Through Italian Innovation and Global Capital
Armon Sharei, PhD - CEO & Founder, Portal Bio
Dan Zheng - Senior Director, Oncology Business Development, Takeda
JM Lee - Business Development, Novo Nordisk
Eckhard Niemeier - Chief Business Officer, Nouscom
Gabriele Brambilla - CEO, Alira Health
7:30 PM - 9:00 PM - Networking Aperitivo
🌍 Why Italy is Your Gateway to Global Biotech Excellence:
Italy has emerged as Europe's biotech powerhouse, with life sciences generating 11% of the nation's GDP and 770 pharmaceutical production sites ranking it second in the EU. The country dominates as Europe's #1 CDMO manufacturing destination, capturing €3.6 billion in value - nearly a quarter of the entire EU market.
The US-Italy partnership has reached new heights, with chemical-pharma representing 18% of total US imports from Italy - the second-largest trade sector. US imports of Italian biotech solutions reached $4.4 billion in 2024, representing an extraordinary 112% year-over-year increase that underscores the accelerating integration of both countries' innovation ecosystems.
🚀 Meet Italy's Innovation Leaders:
Regional Clusters Exhibiting:
Select Friuli Venezia Giulia (European Entrepreneurial Region 2024)
Clust-ER Health & Wellness Emilia-Romagna (€28.5M regional funding)
Cluster Lombardo Scienze della Vita (100+ members, MIND Innovation District)
Tuscany Life Sciences (TLS Bioincubator, Europe's top-25)
HEAL Italia Foundation (70+ entities, 610 researchers)
Bioindustry Park Silvano Fumero (Piedmont's life sciences hub)
Hub Life Sciences Trentino (30,000 m² development project)
Leading Companies & Organizations:
Math Biology (AI-powered zero-invasive screening technology)
Genenta Science (NASDAQ-listed, cell therapy for solid tumors)
Ri.MED Foundation (International biomedical research partnership)
BiomimX (Organs-on-chip technology)
Valpharma Group (450+ employees, 70 countries)
Chemi SpA (50+ years API manufacturing expertise)
CrestOptics (Advanced microscopy solutions)
Diamante (Plant-based autoimmune disease treatments)
In Silico Trials (AI-accelerated drug development)
Menarini Biotech (IND-enabling CDMO services)
Anemocyte (pDNA and mRNA manufacturing)
ICROM Group (IP and technology transfer)
Società Italiana Brevetti (IP protection and enforcement)
🤝 Perfect for:
Biotech/Pharma executives seeking European manufacturing partner
VCs exploring Italy's R&D ecosystem
Business development professionals targeting the fastest-growing European biotech market
Researchers interested in collaboration with world-leading Italian life sciences institutions
📍Location: Federal Reserve Building, Boston - Dress Code: Business casual - Experience: Premium Networking Event with authentic Italian aperitivo
⚠️PLEASE BRING with you the RSVP CONFIRMATION AND AND ID CARD
This exclusive Boston stop is part of Italy's official biotech internationalization strategy and the global Montalcini Tour. The USA remains a strategic partner, with Italian biotech imports to the US growing 112% in 2024 alone, demonstrating the accelerating integration of our innovation ecosystems.